首页> 外国专利> HYPERMNESIA AND ANTIDEMENTIA AGENT CONTAINING DEHYDROEVODIAMINE-HCL AS ACTIVE INGREDIENT

HYPERMNESIA AND ANTIDEMENTIA AGENT CONTAINING DEHYDROEVODIAMINE-HCL AS ACTIVE INGREDIENT

机译:含有去甲双氢安非他明盐酸盐作为有效成分的失忆症和抗精神病药

摘要

PROBLEM TO BE SOLVED: To obtain a hypermnesia and anti-dementia agent exhibiting acethylcholinesterase activity, containing dehydroevodiamine-hydrogen chlorides. SOLUTION: This hypermnesia and anti-dementia agent contains dehydroevodiamine-HCl expressed by the formula or its functional analog as an active component. The compound of the formula is obtained by extracting Evodia rutaecarpa Benth by using an organic solvent (e.g. methanol) or by a chemical synthesis. Other than the compound of the formula, a usual medical additive is suitably mixed to obtain a formulation such as an oral administrating agent or an injection, etc. An administration amount of the formulation is, e.g. 10-250mg in a case of oral administration for an adult (50kg body weight), 10-150mg in a case of intravenous administration and 10-200mg in a case of subcutaneous or intramuscular injection.
机译:解决的问题:要获得具有乙酰胆碱酯酶活性的健忘症和抗痴呆剂,其中应含有脱氢乙二胺-氯化氢。解决方案:该健忘症和抗痴呆剂含有以分子式或其功能类似物表示的脱氢乙二胺-HCl作为有效成分。该式的化合物是通过使用有机溶剂(例如甲醇)或通过化学合成萃取吴茱E(Evodia rutaecarpa Benth)而获得的。除了该式的化合物之外,适当地混合常用的医学添加剂以获得诸如口服给药剂或注射剂等的制剂。成人(50kg体重)口服10-250mg,静脉内注射10-150mg,皮下或肌内注射10-200mg。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号